Chemed Corp

Chemed Corp

Health CareHealth Care Equipment & Services
  • Price (USD)480.63
  • Today's Change1.69 / 0.35%
  • Shares traded202.80k
  • 1 Year change13.02%
  • Beta0.6860
Data delayed at least 15 minutes, as of Sep 18 2020 21:10 BST.
More ▼

Profile data is unavailable for this security.

About the company

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

  • Revenue in USD (TTM)2.02bn
  • Net income in USD262.52m
  • Incorporated1970
  • Employees16.64k
  • Location
    Chemed Corp255 E 5th St Ste 2600CINCINNATI 45202-4138United StatesUSA
  • Phone+1 (513) 762-6690
  • Fax+1 (302) 655-5049
  • Websitehttp://www.chemed.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
NeoGenomics, Inc.404.55m-5.36m3.96bn1.70k--6.05148.589.78-0.0509-0.05093.795.930.492715.114.55237,968.80-0.6532-0.0738-0.7051-0.08343.2945.16-1.33-0.11356.44-2.050.2071--47.7336.2531.5047.8839.64--
LHC Group, Inc.2.06bn118.59m6.38bn15.17k53.294.2638.393.103.793.7965.8747.470.9392--6.90135,794.706.666.268.677.5636.6037.097.094.90--16.250.01860.0014.9323.1850.5734.39-16.35--
Encompass Health Corp4.60bn284.80m6.46bn31.57k22.634.4210.771.402.872.8746.2514.710.7474--8.77145,774.505.967.247.468.9996.0496.197.978.91--3.590.657733.987.6614.1723.3211.4916.557.12
Irhythm Technologies Inc228.19m-65.10m6.93bn997.00--54.13--30.38-2.46-2.468.624.310.943915.268.77228,876.60-26.93-30.28-32.50-36.6174.0472.37-28.53-31.792.99-42.010.2286--45.6858.06-8.32--106.94--
Amedisys Inc1.97bn128.26m7.58bn21.30k60.4010.5150.063.853.873.8759.4722.221.38--8.0792,584.659.088.5712.3711.6940.9141.166.574.28--17.000.35840.0017.6310.186.2757.73-8.06--
Chemed Corporation2.02bn262.52m7.65bn16.64k30.1910.1424.273.7915.9215.92122.4647.391.69199.8815.05121,443.1022.0115.6528.4919.6131.7430.6212.998.630.570981.670.0011.968.755.897.0017.234.008.10
Universal Health Services, Inc.11.28bn734.28m10.02bn67.70k13.911.768.020.88838.488.48129.8366.960.9437--7.42166,589.706.277.387.528.67----6.657.510.94257.580.37995.615.636.765.208.3210.1314.87
Molina Healthcare, Inc.17.68bn797.00m10.94bn10.00k14.185.4612.440.618913.0213.02287.3133.832.43--12.551,768,400.0010.943.3521.478.2318.6715.244.511.35--13.840.50560.00-10.9111.734.2463.76-13.09--
Davita Inc11.52bn823.57m11.01bn65.00k13.894.956.600.9556.296.3486.5517.660.587481.676.09177,290.405.314.477.885.8031.0029.499.047.131.335.540.73270.00-0.1436-2.3014.45-0.4923.63--
Data as of Sep 18 2020. Currency figures normalised to Chemed Corp's reporting currency: US Dollar USD

Institutional shareholders

39.19%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20201.83m11.51%
BlackRock Fund Advisorsas of 30 Jun 20201.37m8.64%
Neuberger Berman Investment Advisers LLCas of 30 Jun 2020634.01k3.98%
Acadian Asset Management LLCas of 30 Jun 2020490.60k3.08%
SSgA Funds Management, Inc.as of 30 Jun 2020400.49k2.52%
Riverbridge Partners LLCas of 30 Jun 2020336.36k2.11%
Fidelity Management & Research Co. LLCas of 30 Jun 2020330.93k2.08%
Renaissance Technologies LLCas of 30 Jun 2020319.00k2.00%
Capital Research & Management Co. (World Investors)as of 30 Jun 2020279.21k1.75%
Wells Capital Management, Inc.as of 30 Jun 2020240.99k1.51%
More ▼
Data from 30 Jun 2020 - 30 Jun 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.